| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
|
5,859 |
5,405 |
$798K |
| 99284 |
|
4,048 |
3,641 |
$752K |
| 99285 |
|
918 |
821 |
$221K |
| 80053 |
|
6,443 |
5,621 |
$93K |
| 99282 |
|
930 |
886 |
$78K |
| 85025 |
|
7,124 |
6,075 |
$53K |
| 96374 |
|
1,349 |
1,204 |
$48K |
| 96375 |
|
1,047 |
897 |
$46K |
| 93005 |
|
1,016 |
923 |
$45K |
| 96361 |
|
1,013 |
865 |
$42K |
| 84443 |
|
1,964 |
1,883 |
$37K |
| 74177 |
|
143 |
131 |
$35K |
| 97110 |
|
612 |
268 |
$26K |
| 71045 |
|
603 |
551 |
$25K |
| 71046 |
|
437 |
404 |
$21K |
| 96372 |
|
848 |
708 |
$20K |
| 36415 |
|
5,942 |
5,363 |
$19K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
324 |
310 |
$16K |
| 80307 |
|
315 |
270 |
$16K |
| 80061 |
|
1,450 |
1,419 |
$15K |
| 87502 |
|
220 |
211 |
$14K |
| 83036 |
|
1,061 |
1,027 |
$10K |
| 99281 |
|
179 |
170 |
$9K |
| 87635 |
|
288 |
269 |
$9K |
| 96365 |
|
119 |
105 |
$8K |
| 81025 |
|
712 |
669 |
$7K |
| 83690 |
|
890 |
784 |
$6K |
| 94640 |
|
57 |
49 |
$6K |
| 81001 |
|
1,075 |
958 |
$6K |
| 87804 |
|
303 |
247 |
$6K |
| 87798 |
|
108 |
91 |
$5K |
| 81003 |
|
2,009 |
1,853 |
$5K |
| G0378 |
Hospital observation service, per hour |
20 |
13 |
$4K |
| 86140 |
|
696 |
639 |
$4K |
| 82306 |
|
165 |
164 |
$4K |
| 87086 |
|
465 |
426 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
260 |
243 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
202 |
197 |
$3K |
| 84439 |
|
345 |
334 |
$3K |
| 84484 |
|
194 |
157 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,251 |
1,089 |
$3K |
| 87430 |
|
212 |
203 |
$3K |
| 87651 |
|
102 |
98 |
$3K |
| 87490 |
|
104 |
99 |
$2K |
| 85652 |
|
567 |
531 |
$2K |
| 80048 |
|
203 |
181 |
$2K |
| 87590 |
|
87 |
82 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
50 |
45 |
$2K |
| 73630 |
|
28 |
24 |
$2K |
| 70450 |
|
14 |
12 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,258 |
1,072 |
$1K |
| 87081 |
|
171 |
163 |
$1K |
| 97140 |
|
47 |
24 |
$1K |
| 87420 |
|
82 |
78 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
104 |
96 |
$1K |
| H0049 |
Alcohol and/or drug screening |
42 |
42 |
$901.22 |
| 96360 |
|
14 |
13 |
$566.43 |
| 83735 |
|
104 |
68 |
$505.15 |
| 87186 |
|
42 |
36 |
$327.82 |
| 85610 |
|
98 |
81 |
$321.71 |
| J2704 |
Injection, propofol, 10 mg |
96 |
95 |
$276.01 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
117 |
115 |
$250.27 |
| 97161 |
|
13 |
12 |
$233.64 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
145 |
144 |
$216.85 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
32 |
28 |
$179.11 |
| 87077 |
|
28 |
24 |
$164.27 |
| A9270 |
Non-covered item or service |
161 |
123 |
$124.15 |
| 87070 |
|
13 |
13 |
$118.60 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
131 |
114 |
$95.62 |
| 82570 |
|
12 |
12 |
$66.47 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
30 |
29 |
$32.17 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
12 |
12 |
$1.32 |